Soomroetal. (2009) reviewed17studiescomparingSSRIs to placebos
SSRIsfound to be moreeffective than placebos in reducingsymptomsofOCDup to 3 monthsaftertreatment
Strength = cost-effective and non-disruptive
drug therapiesrequirelittleinput from the patient in terms of effort and timecompared to CBT which requirespatient to attendregularmeetings and put considerable thought into tackling their problems
drugtherapies are also cheaper as requirelittlemonitoring and costmuchless than psychologicaltreatment
= moreeconomical for healthcaresystem
Limitation = side effects
side effects not always severe but can be enough to stop patient from taking the drug
commonsideeffects of SSRIsincludenausea, headaches and insomnia
when SSRIsaren'teffectivepatient can be prescribedtricyclics which can causehallucinations and irregularheartbeat
Benzodiazepines can cause increasedaggressiveness and longtermimpairment of memory
Limitation = not a lasting cure
Maina et al. (2001) found that patientsrelapse within a fewweeks if medication is stopped
Koran et al. (2007) completed a comprehensivereview of OCDtreatment and suggestedalthoughdrugtherapy may be morecommonlyused, psychotherapies such as CBT should be implementedfirst
Limitation = publication bias
evidence of publicationbiastowardsstudies and research that demonstratepositiveoutcomes of antidepressanttreatment
found that positiveresults were morelikely to be published and studies that weren’t positive often published in a way that conveyed a positiveoutcome
drugcompanies have a stronginterest in the continuingsuccess of psychotherapeuticdrugs and these companies often fundmuch of the research
What are the strengths of the biological approach to treating OCD?
Effectiveness
Cost-effective and non-disruptive
What are the limitations of the biological approach to treating OCD?